Hostname: page-component-cb9f654ff-nr592 Total loading time: 0 Render date: 2025-08-18T02:41:10.916Z Has data issue: false hasContentIssue false
  • English
  • Français

The clinical use of quality-of-life scales in neurological disorders

Published online by Cambridge University Press:  22 February 2013

Francesco Corallo ,
Rosaria De Luca ,
Roberta Leonardi ,
Simona De Salvo ,
Placido Bramanti  and
Silvia Marino
Francesco Corallo
Affiliation:
IRCCS Centro Neurolesi ‘Bonino-Pulejo’, Messina, Italy
Rosaria De Luca
Affiliation:
IRCCS Centro Neurolesi ‘Bonino-Pulejo’, Messina, Italy
Roberta Leonardi
Affiliation:
Social Cooperative Etnos, Caltanissetta, Italy
Simona De Salvo
Affiliation:
IRCCS Centro Neurolesi ‘Bonino-Pulejo’, Messina, Italy
Placido Bramanti
Affiliation:
IRCCS Centro Neurolesi ‘Bonino-Pulejo’, Messina, Italy
Silvia Marino*
Affiliation:
IRCCS Centro Neurolesi ‘Bonino-Pulejo’, Messina, Italy
*
Dr. Silvia Marino, Head of Neurobioimaging Laboratory, IRCCS Centro Neurolesi ‘Bonino-Pulejo’, S.S. 113 Via Palermo, C.da Casazza, 98124-Messina, Italy. Tel: +39 090 60128968; Fax: +39 090 60128850; E-mail:silvimarino@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

Quality of life (QoL) is a growing issue in medicine, particularly in theevaluation of rehabilitative care. The concept of QoL is included in and expandsthe definition of health given by the WHO (World Health Organization) andcomprises complete physical, mental, and social well-being. It expresses thedegree of satisfaction in various areas as a result of the opportunities thatarise during one's lifetime despite the restrictions and impediments that lifeitself puts forth. The last decade has exponentially increased the number ofstudies on QoL, although they are still limited.

Methods

We performed a literature review on the QoL scales used in patients withneurological disorders.

Results

Recent studies have shown the importance of QoL assessment because standardtreatments do not assess the treatment impact felt by the patient. In fact, byunderstanding the impact of treatment on survival and QoL, one can make a clearerinterpretation of the health of the patient.

Conclusion

This review has adopted an innovative holistic methodological approach, whichallowed a global evaluation of the comfort reported by the patients. The scalesapplied in this study allowed to choose the most suitable therapeutic strategiesand programme individual therapeutic treatment.

Keywords

amyotrophic lateral sclerosisdementiamultiple sclerosisParkinson's diseasequality-of-life scales

Information

Type
Review article
Information
Acta Neuropsychiatrica , Volume 25 , Issue 4 , August 2013 , pp. 193 - 205
Copyright
Copyright © Scandinavian College of Neuropsychopharmacology 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1.Perez, L, Huang, J, Jansky, Let al. Using focus groups to inform the Neuro-QOL measurement tool: exploring patient-centered, health-related quality of life concepts across neurological conditions. J Neurosci Nurs 2007;39:342–353.Google Scholar
2.Welsh, MD. Measurement of quality of life in neurodegenerative disorders. Curr Neurol Neurosci Rep 2001;1:346–349.CrossRefGoogle ScholarPubMed
3.Gregory, D, Johnston, R, Pratt, Get al. Dictionary of human Oxford. Quality of Life 2009;4:62–65. ISBN 978-1-4051-3287-9.Google Scholar
4.Staren, ED, Gupta, D, Braun, DP. The prognostic role of quality of life assessment in breast cancer. Breast J 2011;8:152–154.Google Scholar
5.Nakanishi, K, Hanihara, T, Mutai, H, Nakaaki, S. Evaluating the quality of life of people with dementia in residential care facilities. Dement Geriatr Cogn Disord 2011;32:39–44.Google Scholar
6.Jamroz-Wiśniewska, A, Stelmasiak, Z, Bartosik-Psujek, H. Validation analysis of the polish version of the Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL). Neurol Neurochir Pol 2011;45:235–242.Google Scholar
7.Riepe, MW, Mittendorf, T. Quality of life as an outcome in Alzheimer's disease and other dementias – obstacles and goals. BMC Neurology 2009;9:47.CrossRefGoogle ScholarPubMed
8.WHOQOL Group. Study protocol for the World Health Organization Project to develop the quality of life assessment instrument (WHOQOL). Qual Life Res 1993;2:153–159.CrossRefGoogle Scholar
9.Small, GW, Rabins, PV, Barry, PP, Buckholtz, NS. Diagnosis and treatment of Alzheimer disease and related disorders: consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. J Am Med Assoc 1997;267:1363–1371.Google Scholar
10.Brod, M, Stewart, AL, Sands, L, Walton, P. Conceptualization and measurement of quality of life in dementia: the dementia quality of life instrument (DQoL). Gerontologist 1999;39:25–35.Google Scholar
11.Logsdon, RG, Gibbons, LE, McCurry, SM, Teri, L. Assessing quality of life in older adults with cognitive impairment. Psychosom Med 2002;64:510–519.Google Scholar
12.Jenkinson, C, Fitzpatrick, R, Brennan, C, Bromberg, M, Swash, M. Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40. J Neurol 1999;246:16–21.Google Scholar
13.Lawton, MP. A multidimensional view of quality of life. In: Birren JE, Lubben JE, Rowe JC and Deutchman DE, editors. The concept and measurement of quality of life in the frail elderly, vol. 10. New York: Academic Press, 1991. p. 3–27.Google Scholar
14.Jenkinson, C, Fitzpatrick, R. Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: development and validation of the ALSAQ-5. J Neurol Neurosurg Psychiat 2001;70:70–73.Google Scholar
15.Peto, Vet al. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995;4:241–248.Google Scholar
16.Ambs, A, Warren, JL, Bellizzi, KM, Topor, M, Haffer, SC, Clauser, SB. Overview of the SEER – Medicare Health Outcomes Survey linked dataset. Health Care Financ Rev 2008;29:5–21.Google Scholar
17.Brazier, J, Roberts, J, Deverill, M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;22:271–292.Google Scholar
18.Solari, A. Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry 1999;67(2):158–162.CrossRefGoogle ScholarPubMed
19.Hanmer, J, Hays, RD, Fryback, DG. Mode of administration is important in US national estimates of health-related quality of life. Med Care 2007;45:1171–1179.Google Scholar
20.Pittock, SJ, Mayr, WT, McClelland, RLet al. Quality of life is favourable for most patients with multiple sclerosis: a population-based cohort study. Arch Neurol 2004;6:679–686.Google Scholar
21.Martinez-Martin, P, Deuschl, G. Effect of medical and surgical interventions on health-related quality of life in Parkinson's disease. Mov Disord 2007;22:757–765.Google Scholar
22.Hagell, P, Nilsson, MH. The 39-item Parkinson's Disease Questionnaire (PDQ-39): is it a unidimensional construct? Ther Adv Neurol Disord 2009;2:205–214.Google Scholar
23.Edelman, P, Fulton, BR, Kuhn, D, Chang, A. Comparison of three methods of measuring dementia-specific quality of life: perspectives of residents, staff, and observers. Gerontologist 2005;45:27–36.Google Scholar
24.Palmieri, A, Sorarù, G, Lombardi, L. Misure di qualità di vita (QoL) specifiche per la SLA. Validazione dell'adattamento italiano di ALSAQ-40 e ALSAQ-5. Basic Appl Myol 2009;19:217–223.Google Scholar
25.Deuschl, G. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896–908.Google Scholar
26.Moyle, W, Gracia, N. Assessing quality of life of older people with dementia in long-term care: a comparison of two self-report measures. J Clin Nurs 2010;8:125–127.Google Scholar
27.O'Connor, D, Phinney, A, Smith, Aet al. Personhood in dementia care: developing a research agenda for broadening the vision. Dementia 2007;6:121–142.Google Scholar
28.Jenkinson, C, Fitzpatrick, R. Crosscultural evaluation of the short form 8-item Parkinson's Disease Questionnaire (PDQ-8): results from America, Canada, Japan, Italy and Spain. Parkinsonism Relat Disord 2007;13:22–28.Google Scholar
29.Higgins, IJ, Carr, AJ. The clinical utility of quality of life measures. In: Higgins IJ, Carr AJ and Robbins PG, editors. Quality of life, vol 15. London: BMJ Books, 2003. p. 63–78.Google Scholar
30.Behari, M, Srivastava, AK, Pandey, RM. Quality of life in patients with Parkinson's Disease. Parkinsonism and Rel Disord 2005;11:221–226.Google Scholar
31.Korczyn, AD, Davidson, M. Quality of life in Alzheimer's disease. Eur J Neurol 1999;6:487–489.Google Scholar